Screening for trisomy 21 with maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks: A regional experience from Germany

Fetal Diagnosis and Therapy

Volumn 21, Issue 3, 2006, Pages 264-268

  Soergel, P ^a   Pruggmayer, M ^c   Schwerdtfeger, R ^b   Muhlhaus K ^b   Scharf, A ^a,d  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Center for Prenatal Diagnosis and Human Genetics   (Germany)

^c Center for Prenatal Diagnosis and Human Genetics   (Germany)

^d Division of Prenatal Medicine   (Germany)

Author keywords

Human gonadotropin, free; Down's syndrome; Nuchal translucency; Plasma protein A, pregnancy associated; Prenatal diagnosis; Screening

Indexed keywords

BIOLOGICAL MARKER; CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADOLESCENT; ADULT; ALGORITHM; ARTICLE; BIOCHEMISTRY; BLOOD ANALYSIS; CLINICAL TRIAL; COMPUTER ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; FALSE POSITIVE RESULT; FEMALE; FETUS; FETUS OUTCOME; FIRST TRIMESTER PREGNANCY; GERMANY; GESTATIONAL AGE; HUMAN; HUMAN GENETICS; INVASIVE PROCEDURE; LABORATORY TEST; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL BLOOD; NUCHAL TRANSLUCENCY MEASUREMENT; PATIENT COUNSELING; PATIENT INFORMATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; RISK ASSESSMENT; SCREENING; TRISOMY 21;

ADULT; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CROWN-RUMP LENGTH; DOWN SYNDROME; FALSE POSITIVE REACTIONS; FEMALE; GERMANY; GESTATIONAL AGE; HUMANS; MATERNAL AGE; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 33645658606     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000091353     Document Type: Article

References (26)

1. Szabo J, Gellen J: Nuchal fluid accumulation in trisomy-21 detected by vaginosonography in first trimester. Lancet 1990;336:1133.
2. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K: Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 1992;304:867-869.
3. Pandya PP, Brizot ML, Kuhn P, Snijders RJ, Nicolaides KH: First-trimester fetal nuchal translucency thickness and risk for trisomies. Obstet Gynecol 1994;84:420-423.
4. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH: UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998;352:343-346.
5. Gasiorek-Wiens A, Tercanli S, Kozlowski P, Kossakiewicz A, Minderer S, Meyberg H, Kamin G, Germer U, Bielicki M, Hackeloer BJ, Sarlay D, Kuhn P, Klapp J, Bahlmann F, Pruggmayer M, Schneider KT, Seefried W, Fritzer E, von Kaisenberg CS: Screening for trisomy 21 by fetal nuchal translucency and maternal age: a multicenter project in Germany, Austria and Switzerland. Ultrasound Obstet Gynecol 2001;18:645-648.
6. Brambati B, Tului L, Bonacchi I, Shrimanker K, Suzuki Y, Grudzinskas JG: Serum PAPP-A and free beta-hCG are first-trimester screening markers for Down syndrome. Prenat Diagn 1994;14:1043-1047.
7. Berry E, Aitken DA, Crossley JA, Macri JN, Connor JM: Screening for Down's syndrome: changes in marker levels and detection rates between first and second trimesters. Br J Obstet Gynaecol 1997;104:811-817.
8. Bindra R, Heath V, Liao A, Spencer K, Nicolaides KH: One-stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15,030 pregnancies. Ultrasound Obstet Gynecol 2002;20:219-225.
9. Schuchter K, Hafner E, Stangl G, Metzenbauer M, Hofinger D, Philipp K: The first trimester 'combined test' for the detection of Down syndrome pregnancies in 4,939 unselected pregnancies. Prenat Diagn 2002;22:211-215.
10. Spencer K, Spencer CE, Power M, Dawson C, Nicolaides KH: Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience. BJOG 2003;110:281-286.
11. Nicolaides K, Sebire N, Snijders J: Nuchal translucency and chromosomal defects; in The 11-14-Week Scan, the Diagnosis of Fetal Anomalies. New York, Parthenon, 1999.
12. Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH: A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 1999;13:231-237.
13. Wald N, Cuckle H, Wu TS, George L: Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome. Br J Obstet Gynaecol 1991;98:905-908.
14. Spencer K, Nicolaides KH: Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience. BJOG 2003;110:276-280.
15. Snijders RJ, Sundberg K, Holzgreve W, Henry G, Nicolaides KH: Maternal age- and gestation-specific risk for trisomy 21. Ultrasound Obstet Gynecol 1999;13:167-170.
16. Hecht CA, Hook EB: The imprecision in rates of Down syndrome by 1-year maternal age intervals: a critical analysis of rates used in biochemical screening. Prenat Diagn 1994;14:729-738.
17. Federal Statistical Office Germany, branch Health Reporting, Bonn, Germany, www.destatis.de.
18. Nicolaides KH, Brizot ML, Snijders RJ: Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancy. Br J Obstet Gynaecol 1994;101:782-786.
19. Pandya PP, Kondylios A, Hilbert L, Snijders RJ, Nicolaides KH: Chromosomal defects and outcome in 1,015 fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol 1995;5:15-19.
20. Braithwaite JM, Kadir RA, Pepera TA, Morris RW, Thompson PJ, Economides DL: Nuchal translucency measurement: training of potential examiners. Ultrasound Obstet Gynecol 1996;8:192-195.
21. Wüstemann M, Scharf A, Maul H, Baier P, Sohn C: Der Ultraschallsimulator: Eine effektive Trainingsmethode zur Steigerung der Untersucherkompetenz bei der Bestimmung der fetalen Nackentransparenz. Geburtshilfe Frauenheilkd 2002;62:1183-1187.
22. Wald NJ, Kennard A, Hackshaw AK: First trimester serum screening for Down's syndrome. Prenat Diagn 1995;15:1227-1240.
23. Wald NJ, Hackshaw AK: Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome. Prenat Diagn 1997;17:821-829.
24. Snijders RJ, Sundberg K, Holzgreve W, Henry G, Nicolaides KH: Maternal age- and gestation-specific risk for trisomy 21. Ultrasound Obstet Gynecol 1999;13:167-170.
25. Spencer K: Age related detection and false positive rates when screening for Down's syndrome in the first trimester using fetal nuchal translucency and maternal serum free betahCG and PAPP-A. BJOG 2001;108:1043-1046.
26. Wapner R, Thom E, Simpson JL, Pergament E, Silver R, Filkins K, Platt L, Mahoney M, Johnson A, Hogge WA, Wilson RD, Mohide P, Hershey D, Krantz D, Zachary J, Snijders R, Greene N, Sabbagha R, MacGregor S, Hill L, Gagnon A, Hallahan T, Jackson L: First-trimester screening for trisomies 21 and 18. N Engl J Med 2003;349:1405-1413.